![]() |
|
|
Vol. 288, Issue 1, 198-203, January 1999
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan (M.H., H.S., H.K., Y.S.); and Institute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo, Japan (M.N., T.T.)
| |
Abstract |
|---|
|
|
|---|
Cumulative evidence suggests that several organic anions are excreted from the brain to the blood across the blood-brain barrier. In the present study, we carried out a kinetic investigation of the transport activity in MBEC4, an immortalized cell line established from BALB/c mouse cerebral microvessel endothelial cells. The presence of an efflux system in intact cells was examined by using monochlorobimane (MCB), which is conjugated with glutathione intracellularly to produce glutathione bimane (GS-B). The efflux of GS-B was inhibited by ATP depletion and also by 1-chloro-2,4-dinitrobenzne, a precursor of 2,4-dinitrophenyl-S-glutathione, in a concentration-dependent manner. Using this MBEC4 monolayer, we investigated the direction of this transport activity. Although the efflux of GS-B was observed on both luminal and abluminal sides of MBEC4 monolayer, the profile differed for the two sides with respect to the concentration dependence of MCB; the analysis suggested the presence of high-affinity transport system on the luminal side. To investigate the mechanism for the transport, we examined the ATP-dependent uptake of GS-B into the membrane vesicles prepared from MBEC4. ATP-dependent uptake systems with high (Km = 35 nM) and low (Km = 14 µM) affinities were identified. These results suggested that this high-affinity transport system of glutathione conjugates is expressed on the luminal side of the blood-brain barrier and is involved in the detoxification of xenobiotics.
| |
Introduction |
|---|
|
|
|---|
The
blood-brain barrier (BBB) is formed by the tight junction, which
connects each cerebral endothelial cell to its neighbors (Rapoport,
1976
; Bradbury, 1979
; Pardridge, 1991
, 1995
). Along with the
characteristics of these cerebral endothelial cells, i.e., the paucity
of fenestra or pinocytotic vesicles, the tight junction acts as a
barrier to restrict penetration of compounds that are hydrophilic
and/or have a high molecular weight (Rapoport, 1976
; Bradbury, 1979
;
Pardridge, 1991
, 1995
). In terms of a defense system against
xenobiotics, therefore, the BBB was previously believed to function as
a static wall. However, recent studies suggest the presence of
P-glycoprotein on the luminal membrane of the cerebral endothelial
cells, which is responsible for the active efflux of some lipophilic
ligands from the central nervous system (CNS) into the blood (Tatsuta
et al.,1992
; Schinkel et al.,1994
; Tamai and Tsuji, 1996
; Kusuhara et
al., 1997
). Thus, the BBB is now also considered to be involved in the
detoxification of xenobiotics from the brain.
In addition to P-glycoprotein, many kinds of somatic cells have the
ability to export organic anions, including glutathione conjugates
(Kusuhara et al., 1998a
). Based on this transport property, such efflux
transporters are referred to as the glutathione S-conjugates (GS-X) pump (Ishikawa, 1992
). The GS-X pump consists of many
kinds of superfamily members, some of which have been cloned previously (Kool et al., 1997
; Hirohashi et al., 1998
). These include multidrug resistance-associated protein (MRP) overexpressed on some tumor cells
that have acquired the multidrug resistance (Lautier et al., 1997
; Loe
et al., 1997
) and canalicular multispecific organic anion transporter,
which is responsible for the biliary excretion of anionic compounds
(Oude-Elferink et al., 1995
; Yamazaki et al., 1996
; Keppler and
König, 1997
; Kusuhara et al., 1998a
). Considering this
fact, we can assume the presence of a similar transport system on the
BBB (Suzuki et al., 1997
), i.e., the hypothesis should be examined that
the BBB has a function enabling it to export conjugated metabolites of
drugs into the circulating blood and protect the brain from invasion by xenobiotics.
The purpose of the present study was to examine this hypothesis in
MBEC4, a cell line established by infecting mouse cerebral endothelial
cells with simian virus 40. Because several proteins specific to
the cerebral endothelial cells are expressed on MBEC4, and
P-glycoprotein is expressed on the luminal membrane, MBEC4 has been
used as an in vitro experimental model to characterize the transport
properties across the BBB (Tatsuta et al., 1992
). Although we
previously suggested the expression of MRP and/or its related
protein(s) in MBEC4 by Western blot analysis and by demonstrating the
ATP-dependent uptake of 2,4-dinitrophenyl-S-glutathione (DNP-SG) and leukotriene C4 into membrane
vesicles isolated from MBEC4 cells (Kusuhara et al., 1998b
), the
transport properties in the intact cells remain to be clarified.
Moreover, it is essential to determine whether the transporter(s) for
the glutathione conjugates is/are expressed on the luminal or abluminal
membrane of MBEC4 cells. In the present study, we performed a kinetic
investigation of the export of glutathione bimane (GS-B) after
preloading MBEC4 with its precursor, monochlorobimane (MCB)
(Oude-Elferink et al., 1993
). In addition, the mechanism for the
transport of [3H]GS-B was studied using
membrane vesicles isolated from MBEC4 cells.
| |
Materials and Methods |
|---|
|
|
|---|
Materials. Twenty-four-well multiwell plates and Falcon Cell Culture Inserts (0.31-cm2 and 3.0-µm pore size) and Companion TC plates were purchased from Becton Dickinson Labware (Franklin Lakes, NJ). MCB was purchased from Molecular Probes (Eugene, OR). Glycine-2-[3H]glutathione was purchased from New England Nuclear (Boston, MA). Glutathione-S-transferase was purchased from Sigma Chemical (St. Louis, MO). All other chemicals were commercially available, of reagent grade, and were used without further purification.
Cell Culture.
MBEC4 cells, established by immortalizing the
mouse cerebral endothelial cells by the infection of simian virus 40 (Tatsuta et al.,1992
), were used in the present study. Cells were
maintained at 37°C in Dulbecco's modified Eagle's medium (low
glucose) containing 10% fetal bovine serum and antibiotics under an
atmosphere of 5% CO2/95% air.
Transport Study. Cells were seeded on 24-well multiwell plates at a density of 1.0 × 105 cells per well and cultured for 16 h. The medium used in the transport study was composed of 122 mM NaCl, 3 mM KCl, 0.4 mM K2HPO4, 25 mM NaHCO3, 1.4 mM CaCl2, 1.2 mM MgSO4, 10 mM HEPES, and 10 mM glucose, pH 7.4. Five hundred microliters of this medium was added to each well. The cells were preincubated for 20 min with the medium containing 20 µM MCB at 37°C. At time 0, the medium was replaced with fresh medium and incubated at 37°C. At designated times, 100-µl aliquots of medium were collected and the cells were solubilized by adding 500 µl of 10 mM phosphate buffer (pH 6.5) containing 0.1% SDS. To determine the effect of ATP depletion, the medium was replaced at time 0 with fresh medium containing 10 mM NaF, 10 mM NaN3, and 10 mM 3-O-methyl-D-glucose (3-OMG) (instead of glucose). Also, to determine the effect of 1-chloro-2,4-dinitrobenzene (CDNB), the medium was replaced at time 0 with fresh medium containing CDNB at the concentration indicated. In each instance, after a 20-min incubation, medium was collected and cells were solubilized as described previously. All specimens were diluted with 2 ml of 10 mM phosphate buffer (pH 6.5) to determine the concentration of GS-B by measuring the fluorescence intensity (Ex 386 nm; Em 476 nm) in a fluorospectrophotometer (F-2000, Hitachi Ltd., Tokyo, Japan). To analyze the effect of CDNB kinetically, the efflux rate constant of GS-B was calculated by dividing the GS-B efflux velocity by the intracellular amount of GS-B, estimated by taking the mean value of the intracellular content at 0 and 20 min.
Transwell Study. Cells were seeded on cell culture inserts at a density of 1.0 × 104 cells per well and cultured for 3 days to allow them to form a polarized monolayer. The medium used in the transwell study had the same composition as that described above, and 250 µl and 950 µl of medium was added to the luminal and abluminal compartments of the monolayer, respectively. To determine the time-dependent efflux of GS-B, the cells were preincubated for 20 min with medium containing 20 or 10 µM MCB. At time 0, the medium was replaced by fresh medium and incubated at 37°C. At designated times, 100-µl aliquots of medium were collected from the luminal and abluminal compartments and replaced by equivalent volumes of fresh medium. To determine the dependence on the amount of GS-B preloaded, cells were preincubated with MCB at the indicated concentration and at time 0 the medium was replaced by fresh medium and incubated at 37°C. After 20 min incubation, 100-µl aliquots of medium were collected from the luminal and abluminal compartments. All specimens were diluted with 2 ml of 10 mM phosphate buffer (pH 6.5) to measure the fluorescence intensity.
Preparation of Labeled or Unlabeled GS-B. [3H]GS-B was synthesized enzymatically from glycine-2-[3H]glutathione and MCB using glutathione S-transferase from equine liver. Dithiothreitol was removed from the glycine-2-[3H]glutathione solution by extraction with a 10-fold excess of ethyl acetate in samples acidified to pH 2 with 2 M HCl. Extracted glycine-2-[3H]glutathione was reacted with excess MCB in 50 mM potassium phosphate buffer, pH 6.5, at 37°C in the presence of 30 µg/ml of glutathione S-transferase for 60 min. [3H]GS-B was purified from residues using high-performance liquid chromatography with an ODS2 column (LiChrosorb RP-18, ø 4.6 × 250 mm; GL Science, Tokyo, Japan) equipped with UV detector. The mobile phase consisted of CH3CN, and H2O containing 0.1% CF3COOH (13:87) was applied to the column. [3H]GS-B elution was detected by UV detection at 386 nm (purity >99.5%). Unlabeled GS-B was synthesized based on the same principle and also purified using high-performance liquid chromatography.
Membrane Vesicle Preparation.
All steps were performed at
0-4°C. MBEC4 cell monolayers were washed and scraped into
phosphate-buffered saline and washed by centrifugation
(4000g for 10 min). The pellet was stored at
100°C
until required. Membrane vesicles were prepared from defrosted MBEC4
cells according to the method described previously with minor
modification (Müller et al., 1994
). Vesicles were frozen in
liquid nitrogen and stored at
100°C until required. Protein concentrations were determined by the Lowry method using bovine serum
albumin as a standard (Lowry et al., 1951
). The orientation of membrane
vesicles was determined by examining the nucleotide pyrophosphatase in
the presence and absence of 1% Triton X-100 with
p-nitrophenyl-thymidine 5-monophosphate as the substrate (Böhme et al., 1994
).
Transport Study with Membrane Vesicles.
The transport study
was performed using the rapid filtration technique described in a
previous report (Ishikawa et al., 1990
). Transport medium (10 mM Tris,
250 mM sucrose, 10 mM MgCl2, pH 7.4) containing
radiolabeled compounds (15 µl), with or without unlabeled substrate,
was preincubated at 37°C for 3 min and then was rapidly mixed with 5 µl of membrane vesicle suspension (10 µg of protein) with or
without 5 mM ATP and ATP-regenerating system (10 mM creatine phosphate
and 100 µg/ml creatine phosphokinase). To check the ATP dependence,
ATP was replaced by AMP. The transport reaction was stopped by adding 1 ml of ice-cold buffer containing 250 mM sucrose, 0.1 M NaCl, and 10 mM
Tris-HCl (pH 7.4). The stopped reaction mixture was filtered through a
0.45-µm HA filter (Millipore Corp., Bedford, MA) and washed twice
with 5 ml of stop solution. Radioactivity retained on the filter was
determined using a liquid scintillation counter (LSC-3500, Aloka Co.,
Tokyo, Japan). The kinetic parameters for the uptake of GS-B into
membrane vesicles prepared from MBEC4 were estimated from the following
equation:
|
| |
Results |
|---|
|
|
|---|
Export of GS-B from MBEC4.
Figure
1 shows the time profiles for the export
of GS-B from MBEC4 after preincubating the cells with MCB 20 µM for
20 min. The amount of GS-B excreted into medium increased and the
amount remaining in the cells decreased in a time-dependent manner
(Fig. 1). A time-dependent increase was observed in the total amount of
GS-B (Fig. 1), indicating that MCB continued to be conjugated to GS-B
during this period (0-60 min).
|
|
|
Export of GS-B from MBEC4 Monolayer. To clarify the distribution of this export activity, the export of GS-B into the luminal and abluminal compartments from the MBEC4 monolayer was examined. Figure 4 shows the time profiles for the export of GS-B after preincubating the cells with 10 and 20 µM MCB, respectively. After preloading the cells with 10 µM MCB, the amount of GS-B excreted into the luminal compartment was approximately twice that excreted into the abluminal compartment (Fig. 4A), whereas the amount of GS-B excreted into both sides were almost identical at 20 µM (Fig. 4B).
|
|
Transport Study with MBEC4 Membrane Vesicles. The enrichment of leucine amino peptidase was 7.4-fold in plasma membrane vesicles relative to the cell homogenate. In addition, 65% of the membrane vesicles were inside out. Figure 6 shows the time profiles for the uptake of [3H]GS-B (20 nM) into the membrane vesicles prepared from MBEC4 cells in the presence of ATP or 5 mM AMP. The uptake into the membrane vesicles was stimulated by ATP (Fig. 6). The ATP-dependent uptake was linear up to 10 min (Fig. 6).
|
|
| |
Discussion |
|---|
|
|
|---|
In the present study it was suggested that MBEC4 is able to form
glutathione conjugates of compounds (such as MCB) that have invaded the
cells and excrete these conjugates from them (Fig. 1). From the
following evidence, it has been confirmed that this efflux is mediated
by a specific primary active transporter. First, the addition of
metabolic inhibitors such as 3-OMG, NaF, and NaN3 to the medium resulted in a reduction in the amount of GS-B excreted into the medium and an increase in the amount remaining in the cells
(Fig. 2). This result suggests that the efflux of GS-B requires energy.
Second, CDNB inhibited the efflux of GS-B in a concentration-dependent manner. Because we previously indicated that DNP-SG is taken up into
the membrane vesicles isolated from MBEC4 cells in an ATP-dependent manner (Kusuhara et al., 1998b
), this result may be accounted for by
assuming that CDNB is conjugated with glutathione intracellularly to
form DNP-SG, and that the latter competitively inhibits GS-B efflux
(Fig. 3A). Third, the uptake of [3H]GS-B into
plasma membrane vesicles prepared from MBEC4 showed ATP dependence
(Fig. 6).
To investigate the localization of these transport activities, we studied the export of GS-B into the luminal and abluminal compartments from MBEC4 monolayers. After preloading the monolayers with MCB 10 µM, the amount of GS-B excreted into the luminal compartment was approximately twice that excreted into the abluminal compartment (Fig. 4A). In contrast, almost identical amounts of GS-B were excreted into both luminal and abluminal compartments after preloading with 20 µM (Fig. 4B). To characterize this phenomenon from a kinetic point of view, we investigated the concentration dependence of the efflux of GS-B from MBEC4 monolayers. The amount of GS-B excreted into the abluminal compartment was markedly affected by the preloading MCB concentration, whereas that excreted into the luminal compartment was less affected (Fig. 5). These results suggest that the efflux of GS-B into the luminal compartment is almost saturated, even at the lowest concentration (5 µM precursor). In contrast, between 5 and 25 µM MCB, the abluminal efflux of GS-B is under linear conditions (Fig. 5). The contribution of passive diffusion to the efflux of GS-B into the abluminal compartment may be minimal at the higher concentration of MCB, because CDNB markedly reduced the efflux of GS-B after preloading the cells with 20 µM MCB (Fig. 3). Collectively, the affinity of the efflux transport system on the luminal membrane is considered to be higher than that on the abluminal membrane. Under conditions in which the ligand concentration is low enough, preferential luminal efflux should be observed in the BBB (Fig. 5).
To analyze the mechanism for the transport of GS-B, we investigated the uptake of [3H]GS-B into membrane vesicles prepared from MBEC4. The uptake of [3H]GS-B was stimulated in the presence of ATP (Fig. 6), suggesting the existence of primary active transport for the cellular efflux of GS-B. Kinetic analyses showed that two differential systems were involved in the ATP-dependent uptake of GS-B; a high-affinity-low-capacity system (Km = 35 nM, Vmax = 1.12 pmol/min/mg protein) and a low-affinity-high-capacity system (Km = 14 µM, Vmax = 8.83 pmol/min/mg protein) (Fig. 7B). Together with the results from the efflux studies in the monolayers, it seems that the luminal preferential efflux is mediated by the high-affinity transporter.
In our previous report we found that MRP and/or its related protein(s)
are expressed in both MBEC4 and rat cerebral microvessel endothelial
cells (BBB) using Northern and Western blot analyses (Kusuhara et al.,
1998b
). Taken together, the export of glutathione conjugates such as
GS-B, DNP-SG, and leukotriene C4 may be mediated by these transporters. In particular it is suggested that the high-affinity efflux system located on the luminal side of the BBB can
serve as one of the detoxification systems of the CNS by excreting
conjugated metabolites into the circulating blood. Because it
has been shown that cerebral endothelial cells are endowed with high
enzyme activity, including UDP-glucuronosyl transferase and
glutathione-S-transferase (Ghersi-Egea et al., 1994
), and
that the substrate specificity of MRP and its related proteins is very
similar because glutathione and glucuronide conjugates are transported
(Lautier et al., 1996
; Loe et al., 1996a
,b
), it is suggested
that lipophilic compounds invading the BBB are metabolized by these
enzymes and converted into more hydrophilic anions and sequentially
excreted into the circulating blood with the aid of MRP and/or its
related proteins. Indeed, Ishikawa and collaborators (1992) proposed
that this kind of sequential biochemical system of metabolism
(molecular conversion) and excretion (molecular transport) acts as a
defense system to detoxify xenobiotics in the liver and some tumor
cells. In addition, if we consider that several clinically important
anionic drugs [such as methotrexate (Masuda et al., 1997
), pravastatin
(Yamazaki et al., 1996
), temocaprilat (Ishizuka et al., 1997
), and
CPT-11 (Chu et al., 1997a
,b
)] are substrates for canalicular
multispecific organic anion transporter, an MRP-related protein, along
with cumulative in vivo evidence suggesting the presence of an efflux
transport system(s) for organic anions from CNS to circulating blood
across the BBB (Suzuki et al., 1997
), it is possible that the brain
entry of these drugs is restricted by the presence of an efflux
transporter located on the luminal membrane of the BBB.
In conclusion, the results of the present study suggest the expression of a high-affinity transport system for the primary active export of glutathione conjugates on the luminal membrane of MBEC4 cells. This transport system may play an important role in restricting the brain entry of xenobiotics, including clinically important anionic drugs. In addition, monolayers of MBEC4 are an excellent tool for studying the transport of anionic compounds across the BBB.
| |
Footnotes |
|---|
Accepted for publication July 31, 1998.
Received for publication March 24, 1998.
1 This work was supported in part by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan, and the Core Research for Evolutional Sciences and Technology of Japan Sciences and Technology Corporation.
Send reprint requests to: Yuichi Sugiyama, Doctor of Philosophy, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
| |
Abbreviations |
|---|
BBB, blood-brain barrier; CDNB, 1-chloro-2,4-dinitrobenzene; CNS, central nervous system; DNP-SG, 2,4-dinitrophenyl-S-glutathione; GS-B, glutathione bimane; GS-X, glutathione S-conjugates; MCB, monochlorobimane; MRP, multidrug resistance- associated protein; 3-OMG, 3-O-methyl-D-glucose.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J.-H. Sung, K.-H. Yu, J.-S. Park, T. Tsuruo, D.-D. Kim, C.-K. Shim, and S.-J. Chung SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT Drug Metab. Dispos., March 1, 2005; 33(3): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lee, S. Dallas, M. Hong, and R. Bendayan Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations Pharmacol. Rev., December 1, 2001; 53(4): 569 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. DeCory, K. M. Piech-Dumas, S.-S. Sheu, H. J. Federoff, and M. W. Anders Efflux of Glutathione Conjugate of Monochlorobimane from Striatal and Cortical Neurons Drug Metab. Dispos., October 1, 2001; 29(10): 1256 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Nishino, H. Suzuki, D. Sugiyama, T. Kitazawa, K. Ito, M. Hanano, and Y. Sugiyama Transepithelial Transport of Organic Anions across the Choroid Plexus: Possible Involvement of Organic Anion Transporter and Multidrug Resistance-Associated Protein J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 289 - 294. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||